# Coya Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2024

- Company: [Coya Therapeutics, Inc.](/companies/coya.md) (CIK 1835022)
- Form: 10-K/A
- Filed: 2025-04-28
- Accepted by EDGAR: Apr 28, 2025, 17:07 ET
- Period: 2024-12-31
- Accession: 0001193125-25-100816
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1835022/000119312525100816/d892593d10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1835022/000119312525100816/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1835022/000119312525100816/d892593d10ka.htm

Filed Apr 28, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-100816. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.